Drug Efficacy and Potency

Drug Efficacy and Potency - Power vs Punch

• Efficacy ($E_{max}$): "Punch"
  • Maximum therapeutic effect a drug can produce, irrespective of dose.
  • Reflects a drug's intrinsic activity.
  • Clinically, often more important than potency.
  • Example: A high-ceiling diuretic has ↑ $E_{max}$ (greater diuresis) than a low-ceiling one.
• Potency ($ED_{50}$ or $EC_{50}$): "Power" (dose-related)
  • Amount of drug needed to produce 50% of its maximal effect.
  • Reflects drug's affinity for its receptor.
  • A more potent drug requires a ↓ dose for a given effect.
  • Example: Drug A (5mg) is more potent than Drug B (10mg) if both achieve the same therapeutic endpoint at these doses.
• Efficacy and potency are distinct; a drug can be potent but have low efficacy, or vice-versa.

⭐ Efficacy (the maximal effect achievable) is generally of greater clinical importance than potency (the dose required to achieve an effect).

📌 Efficacy = Max Effect; Potency = Pill size (dose needed).

Drug Efficacy and Potency - Curve Appeal

• Dose-Response Curve (DRC): Plots drug effect vs. dose. Essential for comparing efficacy & potency.
  • Graded DRC: Measures intensity of response in an individual.
  • Quantal DRC: Shows percentage of population responding.
• Efficacy ($E_{max}$): 📌 E for Effect (Maximal)
  • Maximum effect a drug can produce, irrespective of dose.
  • Indicated by the height (plateau) of the DRC.
  • Higher $E_{max}$ = greater therapeutic action.
• Potency ($ED_{50}$ / $EC_{50}$): 📌 P for Power (at low dose)
  • Amount of drug needed to produce 50% of $E_{max}$.
  • $ED_{50}$: Dose for 50% maximal effect (in vivo).
  • $EC_{50}$: Concentration for 50% maximal effect (in vitro).
  • Determined by DRC position on dose (X) axis (further left = ↑ potency).

⭐ Efficacy (the maximum effect achievable) is generally more clinically crucial than potency (the dose required for an effect).

Drug Efficacy and Potency - Numbers Game

• Efficacy (Emax): Max effect drug produces. Height of Dose-Response Curve (DRC). Clinically crucial.
• Potency (ED₅₀): Dose for 50% max effect. Position on DRC x-axis (left = more potent).
  • Lower ED₅₀ = Higher potency.
• Key Quantal DRC Values:
  • ED₅₀: Therapeutic effect in 50% population.
  • TD₅₀: Toxic effect in 50% population.
  • LD₅₀: Lethal effect in 50% animals.
• Therapeutic Index (TI): Safety margin.
  • $TI = TD₅₀ / ED₅₀$ (preferred) or $LD₅₀ / ED₅₀$.
  • ↑ TI = Safer drug.
  • Low TI drugs: Warfarin, Digoxin, Lithium, Phenytoin. 📌 Wonderful Doctors Like Patients.

⭐ Potency refers to the amount of drug needed for an effect, while efficacy refers to the maximum possible effect. Efficacy is generally more clinically important.

Drug Efficacy and Potency - Smart Selections

• Efficacy ($E_{max}$): Max effect a drug can produce. Clinically paramount.
  • Higher $E_{max}$ = greater therapeutic effect.
• Potency ($ED_{50}$): Dose required for 50% of $E_{max}$.
  • Lower $ED_{50}$ = higher potency (less drug needed).
• Selection Criteria:
  • 1st: Efficacy. Aim for drug with highest $E_{max}$ for the desired clinical outcome.
  • 2nd: Potency. If $E_{max}$ is similar among drugs, higher potency may allow for lower doses and potentially fewer dose-related side effects.
  • 3rd: Safety. Therapeutic Index (TI) = $TD_{50}/ED_{50}$. Higher TI indicates a safer drug.
    • Narrow TI drugs: Warfarin, Digoxin, Lithium, Phenytoin. 📌 Wonderful Doctors Like Patients.
  • Certain Safety Factor (CSF) = $LD_1/ED_{99}$ (a more stringent safety measure).

⭐ Efficacy ($E_{max}$) is clinically more crucial than potency ($ED_{50}$). An ineffective drug is useless, regardless of its potency.

High‑Yield Points - ⚡ Biggest Takeaways

• Efficacy (Emax) is the maximal effect a drug can produce; often more clinically important.
• Potency (EC50/ED50) is the amount of drug for 50% maximal effect; ↑potency = ↓EC50.
• Full agonists achieve maximal efficacy (Emax).
• Partial agonists have submaximal efficacy; can act as antagonists.
• Competitive antagonists reduce potency (↑ED50), not efficacy; surmountable.
• Non-competitive antagonists reduce efficacy (↓Emax); insurmountable.
• Therapeutic Index (TI) = LD50/ED50; a larger TI indicates a safer drug.